Berberine inhibits NLRP3 Inflammasome pathway in human triple-negative breast cancer MDA-MB-231 cell

Berberine inhibits NLRP3 Inflammasome pathway in human triple-negative breast cancer MDA-MB-231 cell

Abstract Background Breast cancer is still the most common malignant tumor that threatens the female’s life in the world, especially triple-negative breast cancer (TNBC), one of the most difficult subtypes. Lack of targeted therapies brings about urgent demand for novel treatments. In this study we...

Full description

Bibliographic Details
Main Authors: Mingjiang Yao, Xiaodi Fan, Bo Yuan, Norio Takagi, Sai Liu, Xiao Han, Junguo Ren, Jianxun Liu
Format: Article
Language:English
Published: BMC 2019-08-01
Series:BMC Complementary and Alternative Medicine
Subjects:
Berberine
Triple-negative breast cancer
NLRP3 inflammasome
Anti-inflammation
Online Access:http://link.springer.com/article/10.1186/s12906-019-2615-4

Internet

http://link.springer.com/article/10.1186/s12906-019-2615-4

Similar Items